Related Experiment Video
Updated: Sep 23, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients
Steven E Lipshultz1, Stacy D Fisher, Wyman W Lai
1Division of Pediatric Cardiology, University of Rochester Medical Center and Golisano Children's Hospital at Strong 14642, USA. steve_lipshultz@urmc.rochester.edu
Abstract:
Cardiovascular complications are important contributors to morbidity and mortality in HIV-infected patients. These complications can usually be detected at subclinical levels with monitoring, which can help guide targeted interventions. This article reviews available data on types and frequency of cardiovascular manifestations in HIV-infected patients and proposes monitoring strategies aimed at early subclinical detection. In particular, we recommend routine echocardiography for HIV-infected patients, even those with no evidence of cardiovascular disease. We also review preventive and therapeutic cardiovascular interventions. For procedures that have not been studied in HIV-infected patients, we extrapolate from evidence-based guidelines for the general population.
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Rheumatic Heart Disease IV: Nursing Management
Retrovirus Life Cycles
Hypertension IV: Drug Therapy and Lifestyle Modifications
Coronary Artery Disease IV: Preventive Measures
Myocarditis IV: Nursing Management

